Acquisition by Garren Hideki of 85000 shares of Prothena Plc at 30.3 subject to Rule 16b-3

PRTA Stock  USD 14.53  0.75  5.44%   
About 57% of all Prothena Plc's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Prothena plc suggests that some traders are interested. The current market sentiment, together with Prothena Plc's historical and current headlines, can help investors time the market. In addition, many technical investors use Prothena plc stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Prothena Plc Officer: Chief Medical Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 85000 stock option (right to buy) at 30.3 of Prothena Plc by Garren Hideki on 27th of February 2024. This event was filed by Prothena Plc with SEC on 2024-02-27. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Prothena Plc's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Prothena Plc's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Prothena Plc Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Prothena Plc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Prothena Plc Fundamental Analysis

We analyze Prothena Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Prothena Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Prothena Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Prothena Plc is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Prothena plc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Prothena Plc stock to make a market-neutral strategy. Peer analysis of Prothena Plc could also be used in its relative valuation, which is a method of valuing Prothena Plc by comparing valuation metrics with similar companies.

Peers

Prothena Plc Related Equities

STOKStoke Therapeutics   12.07   
0%
100.0%
VTYXVentyx Biosciences   6.12   
0%
50.0%
PCVXVaxcyte   2.95   
0%
24.0%
CGEMCullinan Oncology   1.25   
0%
10.0%
PLRXPliant Therapeutics   0.48   
0%
3.0%
KNSAKiniksa Pharmaceuticals   0.19   
1.0%
0%
MISTMilestone Pharmaceuticals   0.54   
4.0%
0%
NUVLNuvalent   0.56   
4.0%
0%
VRDNViridian Therapeutics   0.65   
5.0%
0%
MDGLMadrigal Pharmaceuticals   0.90   
7.0%
0%
IMCRImmunocore Holdings   1.46   
12.0%
0%
ACLXArcellx   3.16   
26.0%
0%
ONCYOncolytics Biotech   3.30   
27.0%
0%
SCPHScpharmaceuticals   3.89   
32.0%
0%
ETNB89bio   4.93   
40.0%
0%
MCRBSeres Therapeutics   6.82   
56.0%
0%

Complementary Tools for Prothena Stock analysis

When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio